Clin2
NCT06304389Possibly a fitRecruiting

Blue light therapy for epilepsy with vagus nerve stimulation

Refractory Epilepsy

Part of Brain & nervous system clinical trials.

This trial tests if blue light exposure can improve the effects of vagus nerve stimulation (VNS) in people with epilepsy that is hard to control. It also includes some healthy volunteers for comparison. The goal is to find new ways to make VNS work better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
34 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You must have a vagus nerve stimulator (VNS) implanted for at least 3 months.
  • You are between 18 and 60 years old.
  • Your IQ is above 55 (normal or mildly impaired cognitive ability).
  • If you are healthy, you must be between 18 and 35 years old with no neurological or psychiatric conditions.
  • You cannot have any other implanted medical devices (like a pacemaker) or eye diseases.
  • You cannot have a history of brain injury.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04935567Not yet recruiting
EEG test to predict how VNS may help drug-resistant epilepsy

This study looks at an EEG brain test (with light flashing and breathing tasks) to predict whether vagus nerve stimulation (VNS) will help control seizures in adults with drug-resistant epilepsy. It may help doctors choose the best people for VNS and better plan treatment.

Brno
NCT06038929Recruiting
Vagus nerve stimulation and stomach function study

This study looks at how vagus nerve stimulation (VNS) affects how your stomach works, like emptying and stretching. It may help researchers understand the digestive side effects of VNS in people who already have a VNS device for epilepsy or depression.

Minneapolis, Minnesota
NCT03953768Recruiting
Testing a new vagus nerve stimulator for gut and immune health

This study looks at what happens to your immune system and stomach/gut function after getting a vagus nerve stimulator (VNS) for the first time for epilepsy. It may help doctors understand whether the device benefits more than seizures.

Louisville, Kentucky
NCT06016686Recruiting· Phase 1
Recording nerve signals from the vagus nerve in awake humans

This study tests a new way to listen to the vagus nerve in awake people. It may help understand how the nerve controls body functions like heart rate and digestion.

Minneapolis, Minnesota
NCT06334952Recruiting
Personalized brain stimulation for hard-to-treat epilepsy

This study tests a personalized, non-invasive brain stimulation method called tDCS for people with drug-resistant epilepsy that starts in one part of the brain. It aims to reduce seizures in those who cannot have surgery or have not been helped by surgery.

Bordeaux
NCT07010276Not yet recruiting
Brain stimulation for hard-to-treat childhood epilepsy spasms

This trial compares two types of brain stimulation—deep brain stimulation (DBS) and vagus nerve stimulation (VNS)—to see which works better for epileptic spasms in children with drug-resistant epilepsy. If your child has not responded to two or more seizure medicines, this study might help find a new way to control their spasms.

Toronto, Ontario

Hear when a new Refractory Epilepsy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.